The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

Pancreatic cancer, one of the most brutal and deadly diseases, sees approximately 10,800 new cases annually – 30 each day, in the UK – according to Cancer Research UK.It is the ...

Additionally, in 2025, the U.S. Food and Drug Administration (FDA) approved 11 drugs based on clinical trials in which MSK played a pivotal role. “MSK’s clinical research teams made great progress in ...

How your back pain could be a sign of cancer - Abdominal pain or back pain could be symptoms of the UK’s fifth deadliest ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Cancer is often perceived as a fate, but what if it could be avoided even before it manifests? Scientists have just taken a ...

Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

Pancreatic cancer is one of the deadliest malignancies, and it is increasingly occurring in young people — especially women.

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax™, dramatically reduces multiple ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...